Albertsen to discuss “contemporary recommendations” on AS at AUA annual meeting

In one of the more important lectures at the upcoming annual meeting of the American Urological Association, starting in Orlando in a couple of weeks’ time, Dr. Peter Albertsen will be reviewing contemporary recommendations on the practice of active surveillance (AS) for men with low- and very low-risk prostate cancer. … READ MORE …

When is “immediate” adjuvant radiation therapy most appropriate after RP?

The appropriate use of “immediate” adjuvant radiation therapy after a man has a radical prostatectomy (RP) has long been controversial. Although a small number of clinical trials have attempted to address the relative benefits of adjuvant radiation as compared to salvage radiation (with and without additional androgen deprivation), there is still no real consensus. … READ MORE …

How many current, PSA-detected, localized prostate cancers are really appropriate for focal therapy?

It is well understood that current Western screening and diagnostic processes commonly identify patients with low volume, low Gleason grade prostate cancer tumors (e.g., a single biopsy core with < 10 percent of the core  positive for cancer of Gleason score 3 + 3 = 6). … READ MORE …

Better defining appropriate candidates for active surveillance

A forthcoming paper from Tewari’s group at Weill Cornell Medical College in New York describes a new set of nomograms for assessment of risk for worsening prognosis in men with localized prostate cancer who might otherwise be considered appropriate candidates for management under active surveillance. … READ MORE …